Patients Coming Off Anti-Obesity Medications Put On Weight Four Times Faster Compared to Dieters

A recent study suggests that people who come off blockbuster slimming jabs like Wegovy and Mounjaro may regain lost weight far faster than those who stop conventional lifestyle regimens.

Published data in a prominent health publication demonstrates that while overweight individuals can lose a large proportion of their body weight while on the medication, the weight is regained at an average rate of 0.8 kg per month upon discontinuation.

"People purchasing such drugs should be informed of the risk of fast rebound weight gain when the treatment is stopped," warns lead investigator Dr. Susan Jebb.

This pace of recovery means a return to original weight within about one and a half years.

Weighing Therapies

The study, which reviewed 37 of trials involving thousands of patients, contrasted the outcomes of these new drugs with other pills.

Scientists note that individuals who lose weight through dieting generally see a less rapid weight regain—perhaps 100 grams monthly—once they finish.

The Reason for the Rapid Regain

Experts propose the mode of action of the injections accounts for the accelerated rebound.

These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger.

"Long-term administration of GLP-1 levels several times higher than normal could lead to the system to generate a reduced amount of its endogenous hormone, and could diminish responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this GLP-1 'fix' results in hunger is unsuppressed, making binge eating far more likely."

A Chronic Disease?

Health authorities suggest the injections for people with obesity-related health risks, accompanied by prescribed lifestyle changes.

A number of clinicians argue that, considering the likelihood of relapse, the treatment is often ongoing.

This view is supported by drug manufacturers, who state that the results "underscore the chronic nature of excess weight," comparing it to managing conditions like high blood pressure.

Patient Accounts

Individuals who have stopped the medication describe a powerful return of hunger.

"It was like something flipping and you're instantly extremely hungry," said one woman.

This challenge is compounded if patients have not adopted sustainable dietary or behavioural modifications during therapy.

Significant Interest

Survey data show that millions of adults in the UK have tried these injections in the last 12 months, with demand continuing to grow.

• Adoption is higher among females than men.
• The middle-aged age group shows the highest level of interest.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

In conclusion, experts emphasize that while GLP-1 drugs are powerful agents for shedding pounds, they are not a permanent cure and lasting health benefits likely depends on integrated behavioural management.